•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series
AIM ImmunoTech to Participate in Two Upcoming Investor Conferences
Buy Rating Affirmed: AIM ImmunoTech’s Ampligen Shows Promising Oncology Pipeline Progress
AIM ImmunoTech Inc (AIM) (Q1 2024) Earnings Call Transcript Highlights: Strategic Advances Amid Financial Stability
Q1 2024 AIM ImmunoTech Inc Earnings Call Transcript
AIM ImmunoTech GAAP EPS of -$0.12
AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast
Analysts Offer Insights on Healthcare Companies: AIM ImmunoTech (AIM) and Avid Bioservices (CDMO)
Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.